Cumberland Pharmaceuticals Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Cumberland Pharmaceuticals Inc. (CPIX) reported Cost of Goods Sold (Deprecated 2018-01-31) of $1.52 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-08-14
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $1.52M, a 8.72% decline year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.53M, a 10.60% increase year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.15M, a 34.15% increase year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.17M, a 9.75% increase year-over-year.
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $7.37M, a 23.70% increase from fiscal 2016.
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $5.96M, a 19.94% increase from fiscal 2015.
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $4.97M, a 1.68% decline from fiscal 2014.
- Cumberland Pharmaceuticals Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $5.05M, a 7.10% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $1.52M 10-Q · filed 2018-08-14 | $3.05M 10-Q · filed 2018-08-14 | $5.21M derived: sum of 3 quarters · filed 2018-08-14 | $7.37M derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | $1.53M 10-Q · filed 2018-05-09 | $3.68M derived: sum of 2 quarters · filed 2018-05-09 | $5.85M derived: sum of 3 quarters · filed 2018-05-09 | $7.52M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $4.32M derived: sum of 2 quarters · filed 2018-03-09 | $5.99M derived: sum of 3 quarters · filed 2018-08-14 | $7.37M 10-K · filed 2018-03-09 |
| 2017-09-30 | $2.17M 10-Q · filed 2017-11-08 | $3.84M derived: sum of 2 quarters · filed 2018-08-14 | $5.22M 10-Q · filed 2017-11-08 | $6.82M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-06-30 | $1.67M 10-Q · filed 2018-08-14 | $3.05M 10-Q · filed 2018-08-14 | $4.66M derived: sum of 3 quarters · filed 2018-08-14 | $6.63M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $1.38M 10-Q · filed 2018-05-09 | $2.99M derived: sum of 2 quarters · filed 2018-05-09 | $4.96M derived: sum of 3 quarters · filed 2018-05-09 | $6.12M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $3.58M derived: sum of 2 quarters · filed 2018-03-09 | $4.73M derived: sum of 3 quarters · filed 2018-03-09 | $5.96M 10-K · filed 2018-03-09 |
| 2016-09-30 | $1.97M 10-Q · filed 2017-11-08 | $3.13M derived: sum of 2 quarters · filed 2017-11-08 | $4.35M 10-Q · filed 2017-11-08 | $5.94M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $1.16M 10-Q · filed 2017-08-09 | $2.38M 10-Q · filed 2017-08-09 | $3.97M derived: sum of 3 quarters · filed 2018-03-09 | $4.95M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $1.22M 10-Q · filed 2017-05-15 | $2.81M derived: sum of 2 quarters · filed 2018-03-09 | $3.79M derived: sum of 3 quarters · filed 2018-03-09 | $5.03M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.57M derived: sum of 2 quarters · filed 2018-03-09 | $3.81M derived: sum of 3 quarters · filed 2018-03-09 | $4.97M 10-K · filed 2018-03-09 |
| 2015-09-30 | $980.18K 10-Q · filed 2016-11-03 | $2.22M derived: sum of 2 quarters · filed 2016-11-03 | $3.38M 10-Q · filed 2016-11-03 | $4.74M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $1.24M 10-Q · filed 2016-08-05 | $2.40M 10-Q · filed 2016-08-05 | $3.76M derived: sum of 3 quarters · filed 2017-03-13 | $5.10M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $1.16M 10-Q · filed 2016-05-13 | $2.52M derived: sum of 2 quarters · filed 2017-03-13 | $3.86M derived: sum of 3 quarters · filed 2017-03-13 | $5.16M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $2.70M derived: sum of 2 quarters · filed 2017-03-13 | $4.00M derived: sum of 3 quarters · filed 2017-03-13 | $5.05M 10-K · filed 2017-03-13 |
| 2014-09-30 | $1.34M 10-Q · filed 2015-11-06 | $2.64M derived: sum of 2 quarters · filed 2015-11-06 | $3.69M 10-Q · filed 2015-11-06 | $5.84M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $1.30M 10-Q · filed 2015-08-07 | $2.35M 10-Q · filed 2015-08-07 | $4.50M derived: sum of 3 quarters · filed 2016-03-14 | $5.53M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $1.05M 10-Q · filed 2015-05-15 | $3.20M derived: sum of 2 quarters · filed 2016-03-14 | $4.23M derived: sum of 3 quarters · filed 2016-03-14 | $5.38M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $3.18M derived: sum of 2 quarters · filed 2016-03-14 | $4.33M derived: sum of 3 quarters · filed 2016-03-14 | $5.44M 10-K · filed 2016-03-14 |
| 2013-09-30 | $1.03M 10-Q · filed 2014-11-07 | $2.19M derived: sum of 2 quarters · filed 2014-11-07 | $3.29M 10-Q · filed 2014-11-07 | $5.47M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | $1.15M 10-Q · filed 2014-08-08 | $2.26M 10-Q · filed 2014-08-08 | $4.44M derived: sum of 3 quarters · filed 2015-03-09 | $5.36M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $1.11M 10-Q · filed 2014-05-12 | $3.28M derived: sum of 2 quarters · filed 2015-03-09 | $4.20M derived: sum of 3 quarters · filed 2015-03-09 | $5.31M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $3.09M derived: sum of 2 quarters · filed 2015-03-09 | $4.20M derived: sum of 3 quarters · filed 2015-03-09 | $5.05M 10-K · filed 2015-03-09 |
| 2012-09-30 | $921.86K 10-Q · filed 2013-11-06 | $2.02M derived: sum of 2 quarters · filed 2013-11-06 | $2.87M 10-Q · filed 2013-11-06 | $4.82M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | $1.10M 10-Q · filed 2013-08-09 | $1.95M 10-Q · filed 2013-08-09 | $3.90M derived: sum of 3 quarters · filed 2014-03-11 | $5.24M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | $848.55K 10-Q · filed 2013-05-08 | $2.80M derived: sum of 2 quarters · filed 2014-03-11 | $4.14M derived: sum of 3 quarters · filed 2014-03-11 | $5.42M derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $3.29M derived: sum of 2 quarters · filed 2014-03-11 | $4.58M derived: sum of 3 quarters · filed 2014-03-11 | $5.36M 10-K · filed 2014-03-11 |
| 2011-09-30 | $1.34M 10-Q · filed 2012-11-02 | $2.62M derived: sum of 2 quarters · filed 2012-11-02 | $3.41M 10-Q · filed 2012-11-02 | $4.37M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $1.28M 10-Q · filed 2012-08-09 | $2.07M 10-Q · filed 2012-08-09 | $3.02M derived: sum of 3 quarters · filed 2013-03-12 | $3.93M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $786.94K 10-Q · filed 2012-05-04 | $1.74M derived: sum of 2 quarters · filed 2013-03-12 | $2.65M derived: sum of 3 quarters · filed 2013-03-12 | $3.51M derived: sum of 4 quarters · filed 2013-03-12 |
| 2010-12-31 | $954.20K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.86M derived: sum of 2 quarters · filed 2013-03-12 | $2.73M derived: sum of 3 quarters · filed 2013-03-12 | $3.59M 10-K · filed 2013-03-12 |
| 2010-09-30 | $909.43K 10-Q · filed 2011-11-07 | $1.77M derived: sum of 2 quarters · filed 2011-11-07 | $2.63M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $863.73K 10-Q · filed 2011-08-08 | $1.72M 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $4.14M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |